ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis
Europe - BIT:1ELX - US5184391044 - Common Stock
84.8 EUR
+6.8 (+8.72%)
Taking everything into account, 1ELX scores 3 out of 10 in our fundamental rating. 1ELX was compared to 14 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in 4 of the past 5 years.
1ELX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -5.70%, 1ELX is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
The Return On Equity of 1ELX (-29.31%) is worse than 92.86% of its industry peers.
The Return On Invested Capital of 1ELX (4.17%) is worse than 78.57% of its industry peers.
1ELX had an Average Return On Invested Capital over the past 3 years of 4.98%. This is significantly below the industry average of 12.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.7% | ||
| ROE | -29.31% | ||
| ROIC | 4.17% |
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1.3 Margins
With a Operating Margin value of 7.94%, 1ELX is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
1ELX's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 73.96%, 1ELX is doing good in the industry, outperforming 78.57% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.94% | ||
| PM (TTM) | N/A | ||
| GM | 73.96% |
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ELX is destroying value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
The number of shares outstanding for 1ELX has been reduced compared to 5 years ago.
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
2.2 Solvency
1ELX has an Altman-Z score of 3.05. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.05, 1ELX is in line with its industry, outperforming 50.00% of the companies in the same industry.
1ELX has a debt to FCF ratio of 10.92. This is a negative value and a sign of low solvency as 1ELX would need 10.92 years to pay back of all of its debts.
1ELX has a Debt to FCF ratio of 10.92. This is in the lower half of the industry: 1ELX underperforms 78.57% of its industry peers.
1ELX has a Debt/Equity ratio of 1.89. This is a high value indicating a heavy dependency on external financing.
1ELX's Debt to Equity ratio of 1.89 is on the low side compared to the rest of the industry. 1ELX is outperformed by 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.89 | ||
| Debt/FCF | 10.92 | ||
| Altman-Z | 3.05 |
ROIC/WACC0.56
WACC7.44%
2.3 Liquidity
1ELX has a Current Ratio of 1.30. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
1ELX's Current ratio of 1.30 is fine compared to the rest of the industry. 1ELX outperforms 64.29% of its industry peers.
A Quick Ratio of 0.92 indicates that 1ELX may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.92, 1ELX is doing good in the industry, outperforming 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for 1ELX have decreased strongly by -42.31% in the last year.
The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
Looking at the last year, 1ELX shows a decrease in Revenue. The Revenue has decreased by -8.24% in the last year.
1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.04% yearly.
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
3.2 Future
Based on estimates for the next years, 1ELX will show a very strong growth in Earnings Per Share. The EPS will grow by 27.05% on average per year.
Based on estimates for the next years, 1ELX will show a small growth in Revenue. The Revenue will grow by 2.99% on average per year.
EPS Next Y41.68%
EPS Next 2Y40.83%
EPS Next 3Y36.96%
EPS Next 5Y27.05%
Revenue Next Year3.08%
Revenue Next 2Y3.65%
Revenue Next 3Y4.11%
Revenue Next 5Y2.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 65.74, 1ELX can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 1ELX is valued expensively inside the industry as 85.71% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 27.40, 1ELX is valued quite expensively.
With a Price/Forward Earnings ratio of 46.48, 1ELX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1ELX is valued more expensive than 85.71% of the companies in the same industry.
1ELX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.74 | ||
| Fwd PE | 46.48 |
4.2 Price Multiples
1ELX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 78.57% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.06 | ||
| EV/EBITDA | 18.87 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1ELX's earnings are expected to grow with 36.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y40.83%
EPS Next 3Y36.96%
5. Dividend
5.1 Amount
No dividends for 1ELX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ELX (10/17/2025, 7:00:00 PM)
84.8
+6.8 (+8.72%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners95.71%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap30.52B
Analysts69.44
Price Target75.47 (-11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend1.47
Dividend Growth(5Y)4.31%
DP-54.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.72%
Min EPS beat(2)0.44%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)57.77%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)83.43%
EPS beat(12)11
Avg EPS beat(12)80.65%
EPS beat(16)15
Avg EPS beat(16)63.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)9.72%
PT rev (3m)27.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.36%
EPS NY rev (1m)-4.65%
EPS NY rev (3m)-6.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.74 | ||
| Fwd PE | 46.48 | ||
| P/S | 2.48 | ||
| P/FCF | 53.06 | ||
| P/OCF | 27.95 | ||
| P/B | 9.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.87 |
EPS(TTM)1.29
EY1.52%
EPS(NY)1.82
Fwd EY2.15%
FCF(TTM)1.6
FCFY1.88%
OCF(TTM)3.03
OCFY3.58%
SpS34.16
BVpS9.22
TBVpS-4.84
PEG (NY)1.58
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.7% | ||
| ROE | -29.31% | ||
| ROCE | 7.86% | ||
| ROIC | 4.17% | ||
| ROICexc | 5.22% | ||
| ROICexgc | 10.68% | ||
| OM | 7.94% | ||
| PM (TTM) | N/A | ||
| GM | 73.96% | ||
| FCFM | 4.68% |
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexcg growth 3Y-33.25%
ROICexcg growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score4
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.89 | ||
| Debt/FCF | 10.92 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 72.62% | ||
| Cap/Sales | 4.2% | ||
| Interest Coverage | 3.22 | ||
| Cash Conversion | 64.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 3.05 |
F-Score4
WACC7.44%
ROIC/WACC0.56
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
EPS Next Y41.68%
EPS Next 2Y40.83%
EPS Next 3Y36.96%
EPS Next 5Y27.05%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
Revenue Next Year3.08%
Revenue Next 2Y3.65%
Revenue Next 3Y4.11%
Revenue Next 5Y2.99%
EBIT growth 1Y-27.35%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year102.81%
EBIT Next 3Y38.75%
EBIT Next 5Y28.47%
FCF growth 1Y-53.5%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-46.1%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%